These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10395473)

  • 1. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
    Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
    J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
    Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
    J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.
    Lommer BS; Ali SM; Bajpai SN; Brouillette WJ; Air GM; Luo M
    Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1017-23. PubMed ID: 15159560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.
    Chand P; Kotian PL; Morris PE; Bantia S; Walsh DA; Babu YS
    Bioorg Med Chem; 2005 Apr; 13(7):2665-78. PubMed ID: 15755666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
    Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
    Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping.
    Brouillette WJ; Atigadda VR; Luo M; Air GM; Babu YS; Bantia S
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1901-6. PubMed ID: 10450950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
    Stoll V; Stewart KD; Maring CJ; Muchmore S; Giranda V; Gu YG; Wang G; Chen Y; Sun M; Zhao C; Kennedy AL; Madigan DL; Xu Y; Saldivar A; Kati W; Laver G; Sowin T; Sham HL; Greer J; Kempf D
    Biochemistry; 2003 Jan; 42(3):718-27. PubMed ID: 12534284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction.
    Singh S; Jedrzejas MJ; Air GM; Luo M; Laver WG; Brouillette WJ
    J Med Chem; 1995 Aug; 38(17):3217-25. PubMed ID: 7650674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase.
    Sasaki K; Nishida Y; Kambara M; Uzawa H; Takahashi T; Suzuki T; Suzuki Y; Kobayashi K
    Bioorg Med Chem; 2004 Mar; 12(6):1367-75. PubMed ID: 15018909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents.
    Brouillette WJ; Bajpai SN; Ali SM; Velu SE; Atigadda VR; Lommer BS; Finley JB; Luo M; Air GM
    Bioorg Med Chem; 2003 Jul; 11(13):2739-49. PubMed ID: 12788348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
    Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
    Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
    Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
    Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.
    Venkatramani L; Johnson ES; Kolavi G; Air GM; Brouillette WJ; Mooers BH
    BMC Struct Biol; 2012 May; 12():7. PubMed ID: 22559154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.
    Maring CJ; Stoll VS; Zhao C; Sun M; Krueger AC; Stewart KD; Madigan DL; Kati WM; Xu Y; Carrick RJ; Montgomery DA; Kempf-Grote A; Marsh KC; Molla A; Steffy KR; Sham HL; Laver WG; Gu YG; Kempf DJ; Kohlbrenner WE
    J Med Chem; 2005 Jun; 48(12):3980-90. PubMed ID: 15943472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
    Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
    J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.
    Jedrzejas MJ; Singh S; Brouillette WJ; Air GM; Luo M
    Proteins; 1995 Oct; 23(2):264-77. PubMed ID: 8592707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.